EUVIMEDEUVIMED entdecken
Crossref

Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer

Jiaye Lu, Jingwei Li, Ziyou Lin, Huaxuan Li, Linlin Lou, Wen Ding, Shumin Ouyang, Yonghui Wu, Yuanzhen Wen, Xiaobing Chen, Peibin Yue, Yuanxiang Wang und 5 weitere

Cancer Letters · 2023-06 · 564 · 216205

DOI: 10.1016/j.canlet.2023.216205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023-06. Verfasst von Jiaye Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, …. Hauptthemen laut MEDLINE: ErbB Receptors, Lung Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsLung NeoplasmsHumansGefitinibTumor-Associated MacrophagesProtein Kinase InhibitorsDrug Resistance, NeoplasmCell Line, TumorTumor MicroenvironmentSTAT3 Transcription Factor

Stichwörter der Autor:innen

Acquired TKI resistanceCD47Lung cancerSTAT3TAMs

Substanzen

GefitinibErbB ReceptorsProtein Kinase InhibitorsSTAT3 protein, humanSTAT3 Transcription FactorEGFR protein, human

Autor:innen und Institutionen

  • National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou,…
  • Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
  • Increasepharm (Hengqin) Innovative Medicine Institute Co. Ltd, Zhuhai, 519000, China.
  • Department of Medicine, Division of Hematology-Oncology, and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 519000, Macau. Electronic address: jinjianlu@umac.mo.
  • Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: sumszhangjian@163.com.

Zitieren

APA

Lu, J., Li, J., Lin, Z., Li, H., Lou, L., Ding, W., Ouyang, S., Wu, Y., Wen, Y., Chen, X., Yue, P., Wang, Y., Liu, P., Lu, J., Zhang, J., Feng, W., & Zhang, X. (2023). Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters, 564, 216205. https://doi.org/10.1016/j.canlet.2023.216205

Vancouver

Lu J, Li J, Lin Z, Li H, Lou L, Ding W, et al. Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters. 2023;564:216205. doi:10.1016/j.canlet.2023.216205

BibTeX
@article{Lu2023,
  author = {Lu, Jiaye and Li, Jingwei and Lin, Ziyou and Li, Huaxuan and Lou, Linlin and Ding, Wen and Ouyang, Shumin and Wu, Yonghui and Wen, Yuanzhen and Chen, Xiaobing and Yue, Peibin and Wang, Yuanxiang and Liu, Peiqing and Lu, Jinjian and Zhang, Jian and Feng, Weineng and Zhang, Xiaolei},
  title = {Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer},
  journal = {Cancer Letters},
  year = {2023},
  volume = {564},
  pages = {216205},
  doi = {10.1016/j.canlet.2023.216205}
}
Kostenlos starten →